Trey Foskett is the founder of Watchmaker Genomics. Watchmaker Genomics has raised $54M in total funding. Latest round: Series A. Based in Boulder, CO.
Trey Foskett is the CEO and Co-Founder of Watchmaker Genomics, a life sciences company founded in 2019. Watchmaker Genomics specializes in the development of high-stringency applications for reading, writing, and editing DNA and RNA, utilizing an enzyme engineering technology platform. The company has raised a total of $53.5 million in funding, including a $40 million Series A round led by Decheng Capital with co-investment from Eclipse Ventures. Watchmaker Genomics launched its first product in 2020 and has achieved profitability with significant year-over-year revenue growth.
Full founder directory · Investor directory · Company funding database · Fundraising library